Omnicell, Inc.

US$37.34As of Sun 8 Nov 2026, 12:00 UTC
NASDAQ:OMCLHealthcare
Country USA
PE (Fwd) •••
TSR 10Y CAGR 1.36%
Div yield —
ROE 3.52%
Health Information Services
Beta (5Y) 0.89
PE TTM 38.76
TSR TTM 11.23%
Mkt cap US$1.717B
ROIC 3.99%
SE Grade™
Value
Quality
Moat
Consensus
Reference
$38
0.68%
(44.98%)
Hold 6|1|1|11|12
4Q25
1Q26
2Q26
3Q26
Earnings per share$
0.53
0.54
0.52
0.58
11.11%
9.90%
(4.20%)
6.61%
Revenue$M
96.04
99.09
103.1
108.9
6.26%
12.28%
13.56%
18.34%
Peers (US$1.717B)
Cap (US$)
PE
2.239B
—
1.838B
—
Capital
TTM
5Y
10Y
Leveragex
1.905
0.153
0.110
EBIT/Intx
1.304
0.979
0.663
Own earn%
(48.13)
(5.60)
(4.01)
Sh yield%
9.40
29.59
34.79
Owners
Insiders/Inst%
9.61
38.26
Short interest%
4.80
SBC / revenue%
2.73
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
25
Op margin range%
17–22
$1 testx
—
Incr. ROIC%
24